Method Article

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

DOI:

10.3791/56333

November 23rd, 2017

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol serves as a scheme for setting up a functional Tet-ON system in cancer cell lines and its subsequent use, in particular for studying the role of tumor cell-derived proteins in recruitment of monocytes/macrophages to the tumor microenvironment.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in the case that the KD of the protein of interest has a lethal effect on cells or the anticipated effect of the KD is time-dependent, unconditional KD methods are not appropriate. Conditional systems are more suitable in these cases and have been the subject of much interest. These include Ecdysone-inducible overexpression systems, Cytochrome P-450 induction system1, and the tetracycline regulated gene expression systems.

The tetracycline regulated gene expression system enables reversible control over protein expression by induction of shRNA expression in the presence of tetracycline. In this protocol, we present an experimental design using functional Tet-ON system in human cancer cell lines for conditional regulation of gene expression. We then demonstrate the use of this system in the study of tumor cell-monocyte interaction.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Tumor associated macrophages (TAMs) contribute to tumor development by promoting tumor growth, metastasis, and regulating the immune response2. Cancer cells recruit inflammatory monocytes, which infiltrate tumor and differentiate into pro-tumorigenic TAMs3. Infiltration of the tumor with TAMs correlates with poor clinical outcome and has been linked to the immunosuppressive role of macrophages4,5. However, the mechanisms of the recruitment of macrophages to the tumor are not well explored and a better understanding of the involved pathways is crucial for further ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The protocol section that uses human monocytes obtained from healthy volunteers follows the guidelines of the Children's Hospital Los Angeles Human Research Ethics Committee and has been approved by the Institutional Review Board under the Human Material Protocol number: CCI 08-00208.

1. Preparation of Cancer Cell Lines with Tetracycline-regulated shRNA Expression

  1. Cloning of shRNA PAI-1 into Tet-pLKO-puro vector8,9
    1. Design shRNA oligomers that contain AgeI and EcoRI cleavage site at the 5' end, the sense sequence, a 6....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Three shRNA sequences were tested for the most efficient KD of PAI-1. For this, shRNA sequences against PAI-1 and scrambled (Table 1) were cloned into Tet-pLKO-puro expression vector following the protocol described above. The HT-1080 fibrosarcoma cell line was stably transfected with generated constructs and the cells were treated with doxycycline for 3 days. The expression of PAI-1 was verified by Western blotting (Figure 2A

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Composed of a variety of cell types, the TME is crucial for the development of cancer. To ascertain optimal growth conditions, cancer cells attract monocytes through secretion of chemotactic factors. Here we present a protocol for studying the mechanism of monocyte recruitment by tumor cells in vitro. For this purpose, a combination of inducible gene expression system, purification of primary human monocytes, and as an example of a migration assay, the Boyden chamber assay, is used.

T.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors would like to acknowledge Jacqueline Rosenberg for proofreading the manuscript. This work was supported by the US Department of Health and Human Services/National Institutes of Health with a grant to YA DeClerck (grant 5R01 CA 129377) and the TJ Martell Foundation. MH Kubala is the recipient of a Research Career Development Fellowship award of The Saban Research Institute at Children's Hospital Los Angeles.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Tet-pLKO-puro lentiviral vectorAddgene21915
FBS (Tetracycline-free)Omega ScientificFB-15
HistopaqueSigma10771-500ML
EasySep Human Monocyte Enrichment KitStemCell19059
EasySep MagnetStemCell18002
EcoRI HFNEBR3101S
AgeI HFNEBR3552S
Cut Smart bufferNEBB7200S
EndoFree Plasmid Maxi KitQiagen12362
PROMEGA Wizard SV Gel and PCR Cleanup SystemPROMEGAA9281
psPAX vectorAddgene12260
pMD2.G vectorAddgene12259
One Shot Stbl3 Chemically Competent E. coliThermo Fisher ScientificC737303
Hema 3 stain set for Wright-Giemsa stainProtocol123-869
HEK293 cellsATCCCRL-1573
PBSCorning21-031-CV
XhoI restriction enzymeNEBR0146S
LigaseNEBM0202S
Ligase bufferNEBM0202S
EDTA 0.5 M solutionThermo Fisher ScientificR1021
Lipofectamine 2000Invitrogen11668019
The Big Easy" EasySep MagnetStem Cell18001
0.1% Poly-L-Lysine solutionSigma-AldrichP8920
Sodium AcetateSigma-AldrichS7670
Sodium butyrateSigma-AldrichB5887
0.45 μM syringe filtersVWR International28145-479
NaOHSigma-AldrichS5881-500g
Tris(hydroxymethyl)aminomethane (Tris)Invitrogen15504-020
Sodium Chloride(NaCl)Sigma-AldrichS7653-5 kg
Magnesium Chloride (MgCl2)Sigma-AldrichM8266-100g
dithioerythritol (DTE)Sigma-AldrichB8255-5g
ethanol (EtOH)Sigma-Aldrich792780
tryptoneAmrescoJ859-500g
yeast extractFluka70161-500g
Bacto agarBD214010
ampicillinSigma-AldrichA9393-5g
Dulbecco’s Modified Eagle’s Medium (DMEM)Corning10-013-CV
phosphate-buffered saline (PBS)Corning21-031-CV
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)Sigma-AldrichH3375
puromycinSigma-AldrichP9620
Doxycycline hyclateSigma-AldrichD9891-25g
Roswell Park Memorial Institute (RPMI)Corning10-040-CV
0.5 M EDTA pH 8.0Thermo Fisher ScientificR1021
Falcon Permeable Support for 24 Well Plate with 8.0μm Transparent PET MembraneBecton Dickinson353097
Bovine Serum AlbuminSigma-AldrichA7906
Cotton-Tipped Applicator MedlineMDS202000
Protocol Hema 3 STAT pack Fisher Scientific Company123-869
Resolve Immersion Oil, High ViscosityRichard Allan ScientificM4004
Penicillin StreptomycinGibco15140122

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Ryding, A. D., Sharp, M. G., Mullins, J. J. Conditional transgenic technologies. J Endocrinol. 171 (1), 1-14 (2001).
  2. Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. , (2017).
  3. Franklin, R. A.....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Tet ON SystemMonocyte MigrationWestern Blot AnalysisDensity Gradient CentrifugationBoyden Chamber AssayPAI 1 Protein

Related Articles